Optimal MRI sequence for evaluation of metabolism of 5-aminolevulinic acid (5-ALA)

Optimal MRI sequence for evaluation of metabolism of 5-aminolevulinic acid (5-ALA) - MRI sequence for evaluation of metabolism of 5-ALA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026091

Enrollment

Registered

2017-02-10

Start date

2016-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

5-ALA 1Vial 1day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Obtained informed consent Equal or more than 20 years old

Exclusion criteria

Exclusion criteria: Presence of hypersensitivity for Porphyrin Presence of Porphyria Taking medicine as follows Tetracycline antibiotics Sulfonamide New quinolone antibacterial agent Hypericin Food containing horse millet

Design outcomes

Primary

Measure	Time frame
Determination of optimal sequence for detecting the 5-ALA metabolism	—

Countries

Japan

Contacts

Public ContactKazuhiro Saito

Tokyo Medical University Radiology

saito-k@tokyo-med.ac.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026